License information

DUALmembrane license statement
The DUALmembrane technology and the split-ubiquitin technology are subject to several granted and pending patents. Purchase of a DUALmembrane kit includes a limited, non-transferable license to practice the DUALmembrane system for noncommercial purposes only. Commercial entities who wish to purchase DUALmembrane reagents must obtain a separate license from Dualsystems Biotech.
   
Sfi I license statement
Use of the Sfi I cloning strategy is licensed under U.S. Patent #5,595,895 issued to the National Institutes of Health.

CMV license statement
The CMV promoter is covered under U.S. Patent Nos. 5,168,062, and 5,385,839 assigned to the University of Iowa Research Foundation.

DUALXPress license statement
Dualsystems holds a license from Biomedal, S.L. to commercialize CASCADETM and LYTAG vectors, specialized strains, resins and related reagents for the research market. Biomedal is a sublicensee of CASCADE patents and LYTAG patents from Active Motif,
Inc. and Universidad Miguel Hernández, respectively.
   
Trade mark information
DUALmembrane, DUALhybrid, KickStart and cytoY2H are registered trademarks of Dualsystems Biotech AG.
Strep-Tag and Strep-Tactin are registered Trademarks of IBA GmbH.
CASCADE is a trade mark of Active Motif, Inc.